Author

Petra Jessen 1

1 Private Praxis,Altenholz,Germany

A prospective multi-center study on the prevalence of fructose malabsorption in patients withchronic inflammatory bowel disease

Ulf Helwig, Anna Katharina Koch, Kliniken Essen-Mitte,Essen,Germany, Christof Reichel, Petra Jessen, Betina Zietz, Jürgen Büning, Stefan Schreiber, Jost Langhorst

A PROSPECTIVE STUDY TO PREDICT A MILD COURSE OF CROHN’S DISEASE AN INTERIM ANALYSIS OF THE PROGNOS STUDY

Wolfgang Kruis, Ludger Leifeld, Nicolas Hoepffner, Mark Hoesl, Petra Jessen, Michael Mroß, Tobias Klugmann, Sabine Ceplis-Kastner, Birgitta Reimers, Bernd Bokemeyer

NETWORKING AND IMPLEMENTATION OF EVIDENCE-BASED PATHWAYS FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD)

Bernd Bokemeyer, Jana Langbrandtner, Petra Jessen, Heiner Raspe, Angelika Hüppe

PROPENSITY SCORE ADJUSTED REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB VS. ANTI-TNF IN BIOLOGIC-NAÏVE ULCERATIVE COLITIS PATIENTS: INDUCTION PHASE RESULTS FROM THE PROSPECTIVE, OBSERVATIONAL VEDOIBD STUDY IN GERMANY

Bernd Bokemeyer, Sandra Plachta-Danielzik, Romina di Giuseppe, Philipp Efken, Leo Trentmann, Thomas Krause, Robert Ehehalt, Wolfgang Mohl, Martin Hoffstadt, Axel Schweitzer, Petra Jessen, Sina Franzenburg, Petra Hartmann, Stefan Schreiber

SMALL BOWEL CAPSULE ENDOSCOPY IN ULCERATIVE COLITIS – THE CAPCOLITIS STUDY: A PROSPECTIVE OBSERVATIONAL STUDY IN GERMANY

Doreen Luehr, Bernd Bokemeyer, Ulf Helwig, Christian Maaser, Petra Jessen, Stefan Schreiber

VEDOLIZUMAB FOR INFLAMMATORY BOWEL DISEASE IN CLINICAL PRACTICE – EXPERIENCE FROM A PROSPECTIVE GERMAN REGISTRY

Daniel C. Baumgart, Raja Atreya, Oliver Bachmann, Michael Bläker, Bernd Bokemeyer, Norbert Börner, Jürgen Büning, Axel Dignass, Atylla Drabik, Robert Ehehalt, Andreas Fischer, Franz Hartmann, Heinz Hartmann, Stefanie Howaldt, Petra Jessen, Thomas Krummenerl, Tanja Kuehbacher, Andreas Luegering, Jochen Maul, Michael Mross

Item 1 - 6 / 6
1